ArticleEuropean heart journal. Cardiovascular pharmacotherapy2022

Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis.

Junfang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.